First Turn Management, LLC
About First Turn Management, LLC’s 13F portfolio
First Turn Management, LLC is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , First Turn Management, LLC reported $934.7M across 31 US-listed positions (). Its largest position is REVOLUTION MEDICINES INC (RVMD) at 8.3% of the reported book, and its ten biggest holdings make up 54% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | NASDAQ: RVMD REVOLUTION MEDICINES INC | $159.82 −1.76% | 8.3% | 415K | $77.8M |
| 2 | NASDAQ: ABVX ABIVAX SA | $83.83 +2.11% | 7.0% | 490K | $65.3M |
| 3 | NASDAQ: AXSM AXSOME THERAPEUTICS INC. | $134.00 −1.43% | 5.7% | 218K | $53.5M |
| 4 | NASDAQ: ELVN ENLIVEN THERAPEUTICS INC | $44.89 −4.18% | 5.2% | 954K | $48.4M |
| 5 | NASDAQ: BBIO BRIDGEBIO PHARMA INC | $78.01 +1.58% | 5.0% | 633K | $47.2M |
| 6 | NASDAQ: ROIV ROIVANT SCIENCES LTD | $38.73 +0.05% | 5.0% | 1.3M | $47.1M |
| 7 | NASDAQ: UTHR UNITED THERAPEUTICS CORP DEL | $577.34 −1.16% | 4.9% | 85K | $46.0M |
| 8 | NASDAQ: CYTK CYTOKINETICS INC | $51.32 −0.64% | 4.8% | 527K | $44.9M |
| 9 | NASDAQ: XENE XENON PHARMACEUTICALS INC | $37.75 −2.66% | 3.9% | 600K | $36.2M |
| 10 | NASDAQ: CELC CELCUITY INC | $55.60 −4.15% | 3.7% | 329K | $34.4M |
| 11 | NASDAQ: VRDN VIRIDIAN THERAPEUTICS INC | $30.12 +0.20% | 3.3% | 1.7M | $30.7M |
| 12 | NASDAQ: INSM INSMED INC | $119.80 −1.69% | 3.0% | 264K | $28.1M |
| 13 | NASDAQ: QURE UNIQURE NV | $20.30 −2.31% | 3.0% | 609K | $28.0M |
| 14 | NASDAQ: ASND ASCENDIS PHARMA A/S | $270.33 −0.32% | 3.0% | 105K | $28.0M |
| 15 | NASDAQ: PRAX PRAXIS PRECISION MEDICINES I | $305.19 +0.04% | 3.0% | 84K | $28.0M |
| 16 | NASDAQ: DNTH DIANTHUS THERAPEUTICS INC | $83.98 −3.45% | 3.0% | 286K | $27.9M |
| 17 | NASDAQ: PCVX VAXCYTE INC | $58.52 −1.48% | 2.8% | 444K | $25.8M |
| 18 | NASDAQ: MIRM MIRUM PHARMACEUTICALS INC | $92.49 +0.59% | 2.7% | 218K | $25.5M |
| 19 | NASDAQ: PVLA PALVELLA THERAPEUTICS INC NE | $146.58 +1.54% | 2.6% | 156K | $23.9M |
| 20 | NASDAQ: COGT COGENT BIOSCIENCES INC | $27.81 −0.14% | 2.5% | 602K | $23.3M |
| 21 | NASDAQ: ERAS ERASCA INC | $13.76 −0.94% | 2.4% | 1.2M | $22.4M |
| 22 | NASDAQ: ORIC ORIC PHARMACEUTICALS INC | $7.65 −4.37% | 2.3% | 2.0M | $21.8M |
| 23 | NASDAQ: NAMS NEWAMSTERDAM PHARMA COMPANY | $19.74 +1.81% | 2.1% | 582K | $19.7M |
| 24 | NASDAQ: APGE APOGEE THERAPEUTICS INC | $135.07 0.00% | 2.0% | 139K | $18.4M |
| 25 | NASDAQ: RYTM RHYTHM PHARMACEUTICALS INC | $119.04 +2.08% | 1.8% | 154K | $17.1M |
Showing 1–25 of 31 positions on this page reported in this 13F.
- Healthcare100%
- AddedABVXABIVAX SA+5.2%$65.3M
- AddedAXSMAXSOME THERAPEUTICS INC.+15.7%$53.5M
- AddedELVNENLIVEN THERAPEUTICS INC+53.0%$48.4M
- AddedROIVROIVANT SCIENCES LTD+11.8%$47.1M
- AddedCYTKCYTOKINETICS INC+85.9%$44.9M
- AddedCELCCELCUITY INC+56.3%$34.4M
- AddedVRDNVIRIDIAN THERAPEUTICS INC+83.2%$30.7M
- AddedINSMINSMED INC+6.2%$28.1M
- NewASNDASCENDIS PHARMA A/S—$28.0M
- AddedPRAXPRAXIS PRECISION MEDICINES I+96.8%$28.0M
- ReducedRVMDREVOLUTION MEDICINES INC−11.3%$77.8M
- ReducedBBIOBRIDGEBIO PHARMA INC−9.0%$47.2M
- ReducedUTHRUNITED THERAPEUTICS CORP DEL−18.9%$46.0M
- ReducedXENEXENON PHARMACEUTICALS INC−23.7%$36.2M
- ReducedQUREUNIQURE NV−1.1%$28.0M
- ReducedMIRMMIRUM PHARMACEUTICALS INC−45.6%$25.5M
- ReducedCOGTCOGENT BIOSCIENCES INC−36.4%$23.3M
- ReducedAPGEAPOGEE THERAPEUTICS INC−73.0%$18.4M
- ReducedSRRKSCHOLAR ROCK HLDG CORP−39.2%$14.9M
- ReducedKYMRKYMERA THERAPEUTICS INC−59.7%$11.8M
Reading First Turn Management, LLC’s 13F portfolio
First Turn Management, LLC’s $934.7M 13F book is spread across 31 reported positions and is concentrated toward its biggest ideas, with the top ten holdings at 54%. The largest positions carry real weight, so how those names perform matters a lot to the overall book. Its five largest positions are RVMD, ABVX, AXSM, ELVN and BBIO, led by REVOLUTION MEDICINES INC (RVMD) at 8.3% of the portfolio. The heaviest sector exposure is Healthcare (100%).
What First Turn Management, LLC changed last quarter
Between 2026-03-31 and Q2 2026, First Turn Management, LLC was roughly balanced between buying and selling: it opened 6 new positions and added to 13 more, while trimming 11 and closing 8 outright. Against a 31-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was ABIVAX SA (ABVX), and its biggest reduction was REVOLUTION MEDICINES INC (RVMD).
What a 13F does and doesn’t reveal
A 13F captures only First Turn Management, LLC’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names First Turn Management, LLC is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. First Turn Management, LLC's profile on this page is built directly from those filings.
How current is the 13F data on First Turn Management, LLC's page?
It reflects First Turn Management, LLC's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When First Turn Management, LLC files its next quarterly report, this page refreshes automatically.
Can I see First Turn Management, LLC's complete list of holdings?
This page highlights First Turn Management, LLC's largest positions rather than all 31 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under First Turn Management, LLC's filings.
Does a 13F show everything First Turn Management, LLC owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of First Turn Management, LLC's book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why First Turn Management, LLC made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

